- 381
- 597 663
ARDD
Denmark
เข้าร่วมเมื่อ 17 ก.ย. 2020
This is the channel for the Aging Research and Drug Discovery meeting (www.agingpharma.org). We reserve the right to remove derogatory, personal and/or non-scientific comments.
Christina Camell at ARDD2024: Targeting immune function in older organisms
Christina Camell, Institute on the Biology of Aging and Metabolism, USA, presents at the 11th Aging Research and Drug Discovery meeting: Targeting immune function in older organisms
มุมมอง: 108
วีดีโอ
Scotch McClure at ARDD2024: Is Aging Contagious?
มุมมอง 1834 ชั่วโมงที่ผ่านมา
Scotch McClure, Maxwell Biosciences, USA, presents at the 11th Aging Research and Drug Discovery meeting: Is Aging Contagious? Reviewing the known pathogenic drivers of degenerative aging
Anders M. Näär at ARDD2024: RNA Medicines to Increase Healthspan
มุมมอง 1454 ชั่วโมงที่ผ่านมา
Anders M. Näär, University of California, Berkeley, USA, presents at the 11th Aging Research and Drug Discovery meeting: RNA Medicines to Increase Healthspan: Therapeutic Targeting of Pathological RNAs in Aging-Related Diseases
Georg Nebgen at ARDD2024: Value Inflection Points: Successful Balancing of Expectations & Reality
มุมมอง 694 ชั่วโมงที่ผ่านมา
Georg Nebgen, LongeVC, Switzerland, presents at the 11th Aging Research and Drug Discovery meeting: Value Inflection Points: Successful Balancing of Expectations & Reality
Lykke Sylow at ARDD2024: Preserving muscle mass for healthy aging: Old tricks and new targets
มุมมอง 5637 ชั่วโมงที่ผ่านมา
Lykke Sylow, University of Copenhagen, Denmark, presents at the 11th Aging Research and Drug Discovery meeting: Preserving muscle mass for healthy aging: Old tricks and new targets
Collin Ewald at ARDD2024: Improved resilience and proteostasis mediate longevity upon ... in old age
มุมมอง 1717 ชั่วโมงที่ผ่านมา
Collin Ewald, Novartis, Switzerland, presents at the 11th Aging Research and Drug Discovery meeting: Improved resilience and proteostasis mediate longevity upon DAF-2 degradation in old age
Marie Kveiborg at ARDD2024: NNF - from basic biomedical discoveries to ... strategic partnering
มุมมอง 847 ชั่วโมงที่ผ่านมา
Marie Kveiborg, Novo Nordisk Foundation, Denmark, presents at the 11th Aging Research and Drug Discovery meeting: The Novo Nordisk Foundation - from basic biomedical discoveries to clinical translation, through strategic partnering
Laura Goetz at ARDD2024: n=1 trials in the clinic
มุมมอง 15821 ชั่วโมงที่ผ่านมา
Laura Goetz, XPRIZE Healthcare, presents at the 11th Aging Research and Drug Discovery meeting - Longevity Medicine Track: n=1 trials in the clinic
Thomas Rando at ARDD2024: Stem cell aging
มุมมอง 40921 ชั่วโมงที่ผ่านมา
Thomas Rando, UCLA, USA, presents at the 11th Aging Research and Drug Discovery meeting - Longevity Medicine Track: Stem cell aging: From basic science to lifestyle interventions for rejuvenation
Nir Barzilai at ARDD2024: From geroscience to gerotherapeutics
มุมมอง 21821 ชั่วโมงที่ผ่านมา
Nir Barzilai, Albert Einstein College of Medicine, USA, presents at the 11th Aging Research and Drug Discovery meeting - Longevity Medicine Track: From geroscience to gerotherapeutics
James Kirkland at ARDD2024: Potential ... Gerodiagnostic Biomarkers in Healthy Longevity Clinics
มุมมอง 32821 ชั่วโมงที่ผ่านมา
James Kirkland, Robert and Arlene Kogod Center on Aging, USA, presents at the 11th Aging Research and Drug Discovery meeting - Longevity Medicine Track: Potential Clinical Studies of Gerodiagnostic Biomarkers and Gerotherapeutics in Healthy Longevity Clinics
Michael Ringel at ARDD2024: Why we age
มุมมอง 46021 ชั่วโมงที่ผ่านมา
Michael Ringel, BCG, USA, presents at the 11th Aging Research and Drug Discovery meeting - Longevity Medicine Track: Why we age
Elena Bonfiglioli at ARDD2024: Microsoft Healthcare in AI precision medicine
มุมมอง 22921 ชั่วโมงที่ผ่านมา
Elena Bonfiglioli, Microsoft, GM healthcare, Global, presents at the 11th Aging Research and Drug Discovery meeting - Longevity Medicine Track: Microsoft Healthcare in AI precision medicine
Shahaf Peleg at ARDD2024: Upgrading to Animal Models 2.0
มุมมอง 132วันที่ผ่านมา
Shahaf Peleg, Group Leader FBN Dummerstorf, presents at the 11th Aging Research and Drug Discovery meeting - Emerging Science & Technologies Workshop: Upgrading to Animal Models 2.0
Tae Seok Moon at ARDD2024: Systems and synthetic biology
มุมมอง 121วันที่ผ่านมา
Tae Seok Moon, J. Craig Venter Institute, USA, presents at the 11th Aging Research and Drug Discovery meeting - Emerging Science & Technologies Workshop: Systems and synthetic biology: constructing smart and programmable microbes and microbiota to address global problems
Lingyan Shi at ARDD2024: Metabolic nanoscopy for studying aging and diseases
มุมมอง 316วันที่ผ่านมา
Lingyan Shi at ARDD2024: Metabolic nanoscopy for studying aging and diseases
Ed Boyden at ARDD2024: Tools for Analyzing, Controlling, and Simulating Biological Systems
มุมมอง 166วันที่ผ่านมา
Ed Boyden at ARDD2024: Tools for Analyzing, Controlling, and Simulating Biological Systems
Emad Moeendarbary at ARDD2024: Mechanobiology of ageing and emergence ... on-chips technologies
มุมมอง 134วันที่ผ่านมา
Emad Moeendarbary at ARDD2024: Mechanobiology of ageing and emergence ... on-chips technologies
Jacob Hanna at ARDD2024: Synthetic Ex Utero Embryogenesis
มุมมอง 128วันที่ผ่านมา
Jacob Hanna at ARDD2024: Synthetic Ex Utero Embryogenesis
João Pedro Magalhães at ARDD2024: Winter is coming: Cryopreservation as an emerging longevity tech
มุมมอง 30214 วันที่ผ่านมา
João Pedro Magalhães at ARDD2024: Winter is coming: Cryopreservation as an emerging longevity tech
Neal Amin at ARDD2024: Advancing neural replacement using stem cell-derived organoids
มุมมอง 25714 วันที่ผ่านมา
Neal Amin at ARDD2024: Advancing neural replacement using stem cell-derived organoids
Anders Sandberg at ARDD2024: Brain Emulation
มุมมอง 22514 วันที่ผ่านมา
Anders Sandberg at ARDD2024: Brain Emulation
Georg Fuellen at ARDD2024: Validation Requirements for AI-based Intervention-Evaluation
มุมมอง 13114 วันที่ผ่านมา
Georg Fuellen at ARDD2024: Validation Requirements for AI-based Intervention-Evaluation
Indra Heckenbach at ARDD2024: Deep Learning of Cellular Senescence to Predict Cancer Risk
มุมมอง 15314 วันที่ผ่านมา
Indra Heckenbach at ARDD2024: Deep Learning of Cellular Senescence to Predict Cancer Risk
Jing-Dong Jackie Han at ARDD2024: Ethnic-Related Aging Rate Modification
มุมมอง 20614 วันที่ผ่านมา
Jing-Dong Jackie Han at ARDD2024: Ethnic-Related Aging Rate Modification
Nicole Sirotin, MD 🔴 Institute for Healthier Living Abu Dhabi 🔴Interviews with Sponsors 🔴ARDD24
มุมมอง 3692 หลายเดือนก่อน
Nicole Sirotin, MD 🔴 Institute for Healthier Living Abu Dhabi 🔴Interviews with Sponsors 🔴ARDD24
Kennedy Schaal 🔴 Rejuve.Bio 🔴 Interviews with Sponsors 🔴ARDD24
มุมมอง 1833 หลายเดือนก่อน
Kennedy Schaal 🔴 Rejuve.Bio 🔴 Interviews with Sponsors 🔴ARDD24
Hal Gunn, MD 🔴QuBiologics 🔴Interviews with Sponsors 🔴 ARDD24
มุมมอง 1103 หลายเดือนก่อน
Hal Gunn, MD 🔴QuBiologics 🔴Interviews with Sponsors 🔴 ARDD24
Tallyhealth 🔴Melanie Goldey 🔴 Interviews with Sponsors 🔴 ARDD24
มุมมอง 1233 หลายเดือนก่อน
Tallyhealth 🔴Melanie Goldey 🔴 Interviews with Sponsors 🔴 ARDD24
Healthspan Capital 🔴Sebastian A. Brunemeier 🔴 Interviews with Sponsors 🔴 ARDD24
มุมมอง 1963 หลายเดือนก่อน
Healthspan Capital 🔴Sebastian A. Brunemeier 🔴 Interviews with Sponsors 🔴 ARDD24
Bla bla bla…..
Stop funding Washington DC and start funding science of scientists and doctors Last 40 years were a waste of trillions 😳😳😳🍳
From DIscord: "Obviously only a few slides, but RPE reprogramming data @ 12:55 in a mouse model of macular degeneration, and neuron reprogramming data @ 14:25. IMO the new optomotor acuity data in mice w/ reprogrammed RPE cells look better than in their prior work in the optic nerve, but these are very different diseases/models so such a comparison isn't really appropriate, especially without data from a full paper (I'm just trying to put into context the extent of vision improvement here). Also they used an iodide model of macular degeneration - but presumably in older mice that are 12 months old, which is still quite young - which while is a standard mouse model in eye research I doubt it recapitulates normal aging and/or age-related macular degeneration well. David also presents some early MIB-626 (his company's NMN) human trial data showing potential improvements in a few cardiovascular biomarkers like total cholesterol, non-HDL cholesterol, and also improved weight loss"
Breakthrough, Excellent , Doctor's
I can’t spend 20 years in 24/7 pain with chronic disease 😭
Absolutely ❤
How can you have a low calorie yet high fat diet?
I’m looking forward to the results from the fisetin study. Or did it fail??
I have osteoarthritis and needing two hips i want to volunteer for drug trials, is this possible, im healthy, non smoker, can anyone help me
Very interesting.. i Think it won't be on the public radar.. in most countries... or every public pension system will collapse.. The ideal for a government should be stay healthy until a defined age and then die.. live longer = bankrupt (I obviously assume it won't be possible to quickly increase retirement age for most of the jobs)
Google: GlaxoSmithKline and David Sinclair. You’ll come to know more about David. A lot more.
You are brilliant! Thank you for your research!
On VL's comment about not being a ketogenic diet it nevertheless raises ketones and lowers glucose, alot. I've done the official FMD and my own version based on the macro breakdown and in all case my ketones went up to clinical levels (.0.5 mmol) in the 2 to 3 mmol range by day 3 of 5. I take this as just a marker of low insulin. My glucose went down to 70s from high 80s/low 90s. Highly recommended. But do before and after blood work. And when you come out of transition to a good diet and TRE if you can. I did the FMD as two meals/day about 8 hours apart, so a form of TRE combined with FMD.
Os it just me or did she describe a great leap forward to cure blindness...
In his book, Longo shows how to do a DIY version of the FMD. Very easy. I do it once a year.
Yes, I designed my own after doing the official version 3 times. Works very well - Using ketone and glucose levels as markers my version gave same results.
Very interesting. Never heard much about IL-11 before.
Thank you so much! Muchas gracias from Mexico!
Muchas gracias, thank you so much
Very interesting talk. Love biology
Vittorio Sebastiano from Turn Biotechnologies presented at the 10th Aging Research and Drug Discovery conference on cellular and tissue rejuvenation through epigenetic reprogramming. The key points from his presentation are: 1. Epigenetic drift, the progressive accumulation of epigenetic errors in the epigenome, is believed to be a fundamental driver of cellular aging and loss of function. Over time, genes that should be off get turned on and vice versa, impacting many hallmarks of aging. However, unlike the genetic code, the epigenome is reversible and can potentially be reset. 2. Inspiration for epigenetic reprogramming comes from the works of John Gurdon and Shinya Yamanaka showing that somatic cells can be reprogrammed into embryonic-like cells through somatic cell nuclear transfer (Gurdon) or induced pluripotent stem cell techniques (Yamanaka). This suggests aged cells could potentially be made more youthful. 3. In 2014, Sebastiano's group proposed using a controlled partial/transient reprogramming approach to change the age of cells without altering cell identity. They published foundational work on this "epigenetic reprogramming of aging" (ERA) in 2020 using a cocktail of 6 factors delivered as mRNAs. Since then, several studies have validated the approach in various tissues (muscle, skin, brain etc.) and organisms (mice, rats, primates). 4. Turn Biotechnologies is working to translate ERA into clinical applications by combining the biological concept, mRNA delivery vehicles, and lipid nanoparticle (LNP) delivery systems. Using mRNA avoids genomic integration risks and allows fine control of factor expression. Certain factors like MECP2 have beneficial effects when pulsed briefly in combination with others, contrary to some misconceptions. 5. In dermatology, ERA shows promising results: - In primary human fibroblasts, it causes transcriptomic resetting with activation of ECM related genes, anti-inflammatory effects etc. Fibroblast identity genes are appropriately modulated. - In human skin biopsies cultured ex vivo, aging biomarkers are favorably altered after ERA treatment. - An in vivo human skin xenograft model was developed to test ERA delivery and efficacy over several weeks. 6. For immunology, ERA is being explored to rejuvenate T cells: - Treated T cells from old donors proliferate robustly in response to tumor cells without any change in cell identity markers. - They express lower levels of exhaustion markers and maintain better anti-tumor cytotoxic function compared to controls. 7. ERA has potential applications in many tissues like muscle, eye, cartilage, blood, and skin, with dermatology and immunology being the initial focus areas. 8. Delivery of mRNA remains a key challenge, especially achieving sufficient penetration. For skin, microneedling/injections are the near-term approach, with topical solutions being developed. Broader interest and investment in mRNA and gene therapies, catalyzed by COVID vaccines, is expected to accelerate progress on novel delivery systems. In conclusion, Sebastiano presented compelling evidence for ERA as a promising approach to partially reverse cellular aging through transient epigenetic reprogramming. By translating ERA into viable clinical therapies, Turn Bio aims to ultimately increase human healthspan. While delivery hurdles remain, the underlying biology appears sound and reproducible across contexts. ERA represents an exciting frontier in the fight against aging and age-related dysfunction.
Thank you for the great summary :)
Doing my first round of FMD. Primarily interested in anti cancer. Wondering if alternating the FMD with a vegan KETO would stress cancer cells more than just FMD. Example, month 1, FMD, month 2 Ketogenic diet (5 days).
Thanks. Very important. As a 69 yo male very encouraging as I exercise daily these last 12 years. Hba1c stays ~ 5% and hsCRP at <= 0.3 mg/L consistently. Will test IL-6 on morning before exercise to confirm it is low.
The research is absolutely stunning and many people are pending from any news regarding this study. However, I think the difference between targeting "degenerating" or "dead" retina cells in the end of the talk, could have worth a bit more time explanation. Also, do you plan a glaucoma model for the non-human primate test?
I've read his book lifespan couple weeks ago.. and thereafter I'm looking for his interviews
If he becomes my teacher, I’d be honored.
That is amazing!! I will like to hear more...l would like also read the book Lifespan!!😊by David!!
Pure NMN powder from donotage is really good.
I would like to know you said this company is going to make NMN Into a drug, how is that going to affect the rest of the people that you are educating on his benefits, to me that would limit it greatly as to who can get it?
I wonder if he has looked at senescent cells? Are they reduced as in senolytic therapies?
So VERY DISAPPOINTED that you are associated with the WEF. As we all know Klaus Schwab, Gates and the WEF are for depopulation of the world by billions!! Unless these supplements are only for the elites I am very hesitant to believe what is presented. Maybe the average "useless eater", as Klaus calls the general population is not supposed to hear this information or take the supplements!
Did I hear him claim to have dead lifted almost 1,000 pounds?? If so can't he hold a stationary Iron Cross on still rings with 100 extra pounds strapped around his waist?
Did he say, penguins are mammals?
Methionine is better then acuall sam-e for creating sam e and having a anti depressive effect new studies show. Yet many years back aging docs pushed that methionine restriction increase lifespan. Wich makes no sense as methionine is a must for methylation and sam e creation.
I want to move to Singapore now.
Seems criminal that I can't make an informed decision by myself to use rapamycin and take the risks: the possible rewards seem worth it. The whole "we need rapalogues cuz pharma isn't interesting in rapamycin cuz it can't be patented is infuriating.
really the one person to ask a question was some girl who wanted to know what to study...great way to waste it...🙄
I can tell he is a toxic PI the way he talks about his student
She seemed very nervous, but she did a great job. Very interesting talk.
I have done the Prolon 5 day fasting mimicking diet and having the prescribed food made it possible to tolerate the diet because extreme hunger wasn't a factor. I believe in Dr. Longo's research.
I'm on a Six-Day fasting having about 1,000 calories in six days I drink olive oil +pollen spirulina and a handful of walnuts, 23 hours bed rest per day, I have a very small amount of high dense nutrition
Love this
Thank you very much for your valuable information ♥👍👍
What is the mechanism to revert age by applying four Yamanaka factors?
It's important to know basic underlying mechaminism resetting epigenetic setting cell. This will be found by some genius.
A very interesting talk and subject. I'm surprised so few seems to react on it. Only one comment, for example!
A price implies a selective process that perpetuates the cycle of disenfranchisement for those who have no substantial income beyond housing and food.
Unless the cost is covered by third-party payers, such as insurers, charities, and governments.
Wow, that is super-exciting research. Great talk.
Fantastic. Dr.Coray provides comprehensive evidences to prove this old prediction is true.
Bus drive surely could have waited one more question, you have David Sinclair on stage. Come on!
❤❤❤
This was most interesting! The connection between mitocondria and senescence is new to me, and seems to change things compleatly. The similarity between apoptosis and senescence is intriguing! I wonder what effect PhotoBioModulation would have on senescencent cells. Since that affects the mitocondria. Would it push them into apoptosis, into recovery, or neither?
♥️♥️♥️♥️♥️♥️♥️♥️♥️♥️♥️♥️